U.S. Patient Temperature Management Market
The U.S. patient temperature management market size was estimated at USD 1.30 billion in 2023 and is expected to exhibit a CAGR of 7.3% from 2024 to 2030. The market is substantially growing due to increased surgical procedures. This surge is attributed to several factors, including advancements in medical technology, an aging population, increasing number of hypothermia cases and an increasing prevalence of chronic diseases requiring surgical intervention. For instance, according to the Population Reference Bureau (PRB), the population of Americans aged 65 and above is expected to grow from 58 million (2022) to 82 million by 2050, marking a 47% increase. In addition, the proportion of this age group in the total population is projected to rise from 17% to 23%. Overall, the rise in the number of surgical procedures, coupled with the growing emphasis on patient safety and outcomes, is fueling the market growth.
Gather more insights about the market drivers, restrains and growth of the U.S. Patient Temperature Management Market
Patients undergoing cancer treatment, such as chemotherapy or radiation therapy, often experience fluctuations in body temperature as a result of treatment side effects, immune system suppression, or the cancer itself. According to the National Cancer Institute, hyperthermia, also known as thermal therapy or thermotherapy, is a treatment method that involves heating body tissues up to temperatures as high as 113 °F. This approach aims to damage and eliminate cancer cells while minimizing harm to healthy tissue. Effective temperature management is essential during cancer treatment to mitigate the risk of fever, hypothermia, or other temperature-related complications. For instance, according to the American Cancer Society (ACS) in January 2024, the anticipated number of new cancer cases in the U.S. is projected to surpass 2 million, translating to nearly 5,500 new cancer diagnoses each day.
Maintaining optimal body temperature is critical for successful outcomes in cardiac surgeries, catheterization procedures, and other cardiovascular interventions. According to data from the CDC, in 2022, approximately 20.1 million U.S. adults have coronary artery disease, and 805,000 Americans have a heart attack each year. The upward trend in these figures is linked to the growing prevalence of preventive cardiac surgeries conducted each year
Browse through Grand View Research's Medical Devices Industry Research Reports.
- The global pediatric oral care market was estimated at USD 9.6 billion in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030.
- The global pediatric wheelchair market size was estimated at USD 2.10 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2030.
U.S. Patient Temperature Management Market Segmentation
Grand View Research, Inc. has segmented the U.S. patient temperature management market based on type, application, and end-use.
U.S. Patient Temperature Management Type Outlook (Revenue, USD Million, 2018 - 2030)
- Patient Warming Systems
- Conventional Warming Systems
- Blankets
- Pads
- Surface Warming Systems
- Warming Systems
- Blankets
- Pads
- Others
- Open-basin
- Fluid Warmers
- Patient Cooling Systems
- Conventional Cooling Systems
- Blankets
- Pads
- Surface Cooling Systems
- Cooling Systems
- Blankets
- Pads
- Others
- Conventional Cooling Systems
- Dual Technology
- Surface Warming Systems
- Intravascular Warming Systems
- Consumables
- Irrigation Drapes
- Fluid Warmer Drapes
- Scope Warmer Drapes
- Conventional Warming Systems
U.S. Patient Temperature Management Application Outlook (Revenue, USD Million, 2018 - 2030)
- General Surgery
- Cardiology
- Pediatrics
- Neurology
- Orthopedic Surgery
- Thoracic Surgery
- Others
U.S. Patient Temperature Management End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Operating rooms
- Neonatal ICU
- ICUs
- Emergency room
- Preoperative Care Units
- Postoperative Care Units
- Acute Care
- Burn Centers
- Cath Labs
- Neurological Care Units
- Others
Key U.S. Patient Temperature Management Companies:
- Stryker Corporation
- Zoll Medical Corporation
- Medtronic
- Bard Medical
- 3M Company
- Pintler Medical
- ECOLAB INC.
- Currie Medical, Inc.
- Belmont Medical Technologies
- Cincinnati Sub-Zero Products, LLC
Recent Developments
- In January, 2024, SourceMarkannounced a partnership with Gentherm Medical, a well-known manufacturer of systems for controlling patient temperature. Building on their previous collaboration, SourceMark is now the U.S. distributor for a few Gentherm patient warming product lines. traditional Arrow Midline, both of which come in single double lumen options.
- In June, 2023, Drägerwerk AG Co. KGaA introduced the FDA-cleared Babyroo TN300, an open warmer providing supportive lung protection and temperature stability. It facilitates clinician access to routine care, emergencies, and procedures during the baby’s hospital stay while promoting family-centered care for healthy outcomes.
- In July, 2024, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd., which produced patient temperature control systems and other medical supplies equipment.
Order a free sample PDF of the U.S. Patient Temperature Management Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
